10 studies were found.

1.		Recruiting	Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer Condition: Breast Cancer
2.		Recruiting	EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-segment Elevation Acute Coronary Syndrome Condition: Myocardial Ischemia
3.		Recruiting	Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections Condition: Mycoses
4.		Recruiting	Peg-Ifn Dose Evaluations for Previously Untreated Subjects with Chronic Hepatitis C Infected w/ Genotype 1 Condition: Chronic Hepatitis C
5.		Recruiting	Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients with Cirrhosis Conditions: Chronic Hepatitis C; Cirrhosis
6.		Recruiting	PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to alpha-Interferon Plus Ribavirin Conditions: Chronic Hepatitis C; Liver Fibrosis; Cirrhosis
7.		Recruiting	Prevention of Disease Progress in Chronic Hepatitis C Patients with Liver Fibrosis Conditions: Chronic Hepatitis C; Liver Fibrosis
8.		Recruiting	Prophylaxis Trial of Posaconazole vs. Standard Azole Therapy for Neutropenic Patients Conditions: Leukemia, Myelocytic, Acute; Myelodysplastic Syndromes; Neutropenia
9.		Recruiting	Temozolomide for Treatment of Brain Metastases from Non-Small Cell Lung Cancer Conditions: Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Brain Neoplasms
10.		Recruiting	Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma Condition: Melanoma